Editorial Board

Vaccines & Vaccination Open Access

Home VVOA Editorial Board Reinhard Glueck

Share this profile

LinkedIn Twitter / X

✓ Link copied!

Reinhard Glueck

Reinhard Glueck

Editorial Board Member
Cadila Healthcare Limited Switzerland Member since 2017

Biography

Reinhard Glueck is the Chief Scientific Officer at Zydus Cadila Healthcare, Ahmedabad. He is chairing the Zydus research center, Etna Biotech, Catania, Italy, too. Previously he holds the same position at former Berna Biotech, today Crucell. He is an expert in innovative vaccine development. He has first in history developed the so called Immunostimulatoary reconstituted influenza virosome or virosome technology which is today applied in millions of influenza and hepatitis A vaccines worldwide. He also introduced new adjuvants such as non-toxic HLT for influenza vaccines which has obtained marketing authorization in Switzerland in 2001. In his role of CSO at Zydus Cadila Healthcare Ltd. he has entered into collaboration with world class institutions (IDRI, Thelormedix, Statens Serum Inst. Denmark, ICGEB, New Delhi and others) to evaluate new and better adjuvants. Reinhard Glueck was until recently the President of Swiss Biotech Association and has been awarded with the Honorary Presidentialship of this organization. He is member of many scientific boards, worldwide. In his career he published more than 100 peer reviewed papers and holds more than 10 patents.

Research Interests

vaccines vaccinology

Other Editorial Board Members

Submit Manuscript

Chat with us on WhatsApp

Welcome to Medwin Publishers. How can we help you today?